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SUMMARY
Mutations affecting the levels of microRNA miR-137
are associated with intellectual disability and schizo-
phrenia. However, the pathophysiological role of
miR-137 remains poorly understood. Here, we
describe a highly conserved miR-137-binding site
within the mRNA encoding the GluA1 subunit of
AMPA-type glutamate receptors (AMPARs) and
confirm that GluA1 is a direct target ofmiR-137. Post-
synaptic downregulation of miR-137 at the CA3-CA1
hippocampal synapse selectively enhances AMPAR-
mediated synaptic transmission and converts silent
synapses to active synapses. Conversely, miR-137
overexpression selectively reduces AMPAR-medi-
ated synaptic transmission and silences active syn-
apses. In addition, we find that miR-137 is transiently
upregulated in response to metabotropic glutamate
receptor 5 (mGluR5), but not mGluR1 activation.
Consequently, acute interference with miR-137 func-
tion impedes mGluR-LTD expression. Our findings
suggest that miR-137 is a key factor in the control
of synaptic efficacy and mGluR-dependent synaptic
plasticity, supporting the notion that glutamatergic
dysfunction contributes to the pathogenesis of
miR-137-linked cognitive impairments.
INTRODUCTION
Learning and memory processes rely on activity-dependent
changes in synaptic strength. A fundamental mechanism for
the modification of synaptic strength is the insertion or removal
of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
receptors (AMPARs) at the postsynaptic membrane (Bassani
et al., 2013; Citri and Malenka, 2008; Huganir and Nicoll, 2013).
Long-term potentiation (LTP) and long-term depression (LTD)
are two central mechanisms of synaptic plasticity depending
on changes in AMPAR that mediate the majority of fast synaptic
transmission (Malinow andMalenka, 2002). In the hippocampus,
two independent forms of LTD coexist, the N-methyl-D-aspar-
tate receptor (NMDAR)-LTD and the group I metabotropic gluta-
mate receptor (mGluR)-LTD, each induced through distinct
signaling cascades (Collingridge et al., 2010; Oliet et al., 1997).
Translation from dendritically localized mRNAs is a primary pro-
cess for the induction of mGluR-LTD (Huber et al., 2000; Klann
and Dever, 2004; Snyder et al., 2001). The prevailing model is
that group I mGluRs rapidly trigger the local synthesis of new
dendritic proteins that are required for LTD by increasing the
rate of AMPAR endocytosis at active synapses (Lu¨scher and
Huber, 2010; Waung and Huber, 2009). Among the locally trans-
lated proteins are Arc/Arg3.1 (Jakkamsetti et al., 2013; Park
et al., 2008; Waung et al., 2008), Map1b (Davidkova and Carroll,
2007), STEP1 (Zhang et al., 2008), and oligophrenin-1 (Nadif
Kasri et al., 2011). Interestingly, different forms of intellectual
disability (ID) have been linked to defective mGluR-LTD, confirm-
ing the tight regulation of AMPAR function at mature synapses
through local protein synthesis as an essential form of plasticity
and cognition (Aschrafi et al., 2005; Auerbach et al., 2011;
Bateup et al., 2011; Lu¨scher and Huber, 2010).
Local translation-dependent synaptic LTD is tightly controlled
by a number of different post-transcriptional mechanisms, such
as the ubiquitin-proteasome system (Hou et al., 2006; Yashiro
et al., 2009), translation initiation and elongation (Costa-Mattioli
et al., 2005), and by microRNAs (miRNAs) (Manakov et al.,
2009).MiRNAs are small, evolutionarily conserved signalingmol-
ecules that act as silencing regulators of mRNA targets. Disrup-
tion of miRNA expression or signaling impairs synaptic plasticity
and has been associated with severe cognitive impairment in
mice (Hansen et al., 2013; Konopka et al., 2010) and humans
(Ripke et al., 2013; Willemsen et al., 2011). Consistent with these
notions, inducing LTP or LTD rapidly alters the levels of many
different miRNAs in hippocampal neurons (Park and Tang,
2009; Wibrand et al., 2010). MiRNAs affect synaptic plasticity
by directly targeting synaptic receptors or their downstream tar-
gets (Dutta et al., 2013; Fiore et al., 2014; Kocerha et al., 2009;
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Letellier et al., 2014; Saba et al., 2012; Schratt et al., 2006),
including LTD proteins such as Arc and Map1b (Chen and
Shen, 2013; Wibrand et al., 2012). These findings suggest that
variation in miRNA expression affects synaptic protein levels
and, consequently, synaptic plasticity by controlling the stability
and translation of dendritically localized transcripts.
Using SNP microarray analysis, we have identified microdele-
tions encompassing MIR137 in a number of unrelated families
with genetic forms of ID (Willemsen et al., 2011). These deletions
cause reduced miR-137 expression and increased transcript
levels for miR-137 target genes such as KLF4, MITF, and EZH2
in ID patient-derived cell lines. Moreover, a SNP linked to
MIR137 has shown genome-wide significant association with
schizophrenia (SZ) and has been associated with a number of
SZ endophenotypes (Duan et al., 2014; Guella et al., 2013;
Kwon et al., 2013; Ripke et al., 2013). Initial studies suggest
that miR-137 modulates the proliferation and differentiation of
adult neuronal stem cells in vitro and in vivo (Szulwach et al.,
2010), and it negatively regulates dendrite morphogenesis and
spine development in newborn neurons in the dentate gyrus
(DG) by targeting the E3 ubiquitin ligase Mindbomb-1 (Smrt
et al., 2010). This is in line with our recent findings showing
that miR-137 is synaptically enriched (Willemsen et al., 2011),
and supports the notion that cognitive deficits observed in hu-
man patients can be attributed to altered dendritic spine
morphology and disrupted synaptic function (Nadif Kasri and
Van Aelst, 2008; Pavlowsky et al., 2012). However, the molecular
mechanisms by which miR-137 controls synaptic transmission
and plasticity remain elusive.
Here, we investigated the postsynaptic function of miR-137
specifically at the CA3-CA1 synapse of the hippocampus. We
identified AMPAR subunit GluA1 as a target of miR-137, and
we found that this miRNA stimulates the silencing of synapses
by selectively decreasing AMPAR subunit GluA1 surface expres-
sion, thereby affecting synaptic maturation. Moreover, miR-137
maturation was rapidly enhanced upon mGluR activation, which
is required for the expression of mGluR-dependent LTD. Thus,
our data unveil a critical role for miR-137 in controlling synaptic
strength at the CA3-CA1 synapse and link genetic deficits in
MIR137 to glutamatergic dysfunction, which may ultimately
contribute to the pathogenesis of cognitive impairments.
RESULTS
AMPAR Subunit GluA1 Is a Direct Target of miR-137
Bioinformatics studies revealed the presence of a highly
conserved miR-137 binding site in the 30-UTR of AMPAR subunit
GluA1, but not for other AMPAR subunits (Figure 1A), suggesting
that this miRNA targets GluA1. We transfected hippocampal
neurons at 14 days in vitro (DIV) with either a luciferase reporter
plasmid containing the GluA1 30UTR (wild-type [WT]) or an miR-
137 binding-site-mutated GluA1 30UTR (mutant) (Figure 1B).
Luciferase activity was assessed using an miR-137-seques-
tering sponge vector (Figure S1). Neurons infected with the
sponge-miR-137 virus exhibited an increased luciferase signal
when expressing the GluA1-30UTR (Figure 1B), whereas no
effect was seen with the mutated form of GluA1. Similarly, lucif-
erase activity was increased when the GluA1-30UTRWT neurons
were exposed to a previously validated locked nucleic acid LNA-
miR-137 (Willemsen et al., 2011), whereas this increase was
absent in the mutant condition, suggesting a targeting of this
binding site by miR-137 (Figure 1B).
Western blot analysis revealed that GluA1 protein expression
was significantly increased in the sponge-miR-137-expressing
neurons, whereas GluA1 expression was significantly reduced in
the miR-137-expressing neurons (Figures 1C and 1D). Of note,
GluA1mRNA expressionwas unaffected bymiR-137, suggesting
that the changes inGluA1protein levelsbymiR-137 is regulatedat
the level of translation rather than transcription (Figure 1E).
We observed a significant increase in surface GluA1 (sGluA1)
expression at synapses of sponge-miR-137-expressing hippo-
campal neurons, whereas sGluA1 levels were reduced during
miR-137 overexpression (Figures 1F and 1G), supporting the
notion that AMPAR subtype GluA1 is directly targeted by
miR-137.
miR-137 Regulates Excitatory Synaptic Transmission at
the Hippocampal CA3-CA1 Synapse
Next, we examined the role of endogenous miR-137 on synaptic
function by assessing the effects of reducedmiR-137 expression
on synaptic transmission at the hippocampal CA3-CA1 synapse.
Simultaneous whole-cell recordings of evoked excitatory post-
synaptic currents (eEPSCs) from an 8–10-DIV CA1 pyramidal
neuron expressing sponge-miR-137 and an adjacent non-
infected neuron were performed. miR-137 downregulation re-
sulted in a potentiation of AMPAR-mediated transmission, but
not NMDAR-mediated transmission (Figure 2A). Conversely,
miR-137 overexpression significantly depressed AMPAR-medi-
ated transmission, but not NMDAR-mediated transmission
(Figure 2B), indicating that modulation of miR-137 levels is asso-
ciated with opposing effects toward AMPAR-mediated synaptic
transmission.
The observed changes are likely due to a postsynaptic effect,
since only CA1 neurons were genetically manipulated at the
CA3-CA1 synapse and we did not observe any change in pre-
synaptic release probability, as measured by a paired-pulse
stimulation paradigm (Figure 2C). Collectively, these results sug-
gest that miR-137 controls excitatory synaptic strength in a cell-
autonomous manner.
The changes in AMPAR-mediated transmission could be
based on a change in synaptic AMPARs levels at individual
synapses, a change in the number of functional synapses, or
both. We therefore measured miniature excitatory postsynaptic
currents (mEPSCs) in the sponge-miR-137- and the miR-137-
infected neurons as compared to non-infected cells. While
sponge-miR-137-infected neurons exhibited no change in
amplitude, they showed an increase in the frequency of
mEPSCs. In contrast, neurons overexpressing miR-137 showed
a decreased mEPSC frequency without exhibiting any changes
in amplitude (Figures 2D and 2E). A change in frequency usually
reflects a change in the number of active synapses or presynap-
tic release probability. However, since alterations in miR-137
levels did not elicit any changes in presynaptic release probabil-
ity, these results suggest that modulation of miR-137 levels in
hippocampal slices resulted in a change in the number of func-
tional synapses.
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miR-137 Promotes Silencing of Active Synapses
miR-137 was shown to play a critical role in neuronal morpho-
genesis during the development of newborn neurons in the DG
in vivo (Smrt et al., 2010).
We therefore examined the role of miR-137 in dendritic spine
formation or maintenance in 21-DIV hippocampal neuronal cul-
tures. Image analysis revealed that, while no changes were
observed in spine type and size by altering miR-137 levels, spine
density of sponge-miR-137-infected cells was increased,
whereas no effects on spine density were seen upon miR-137
overexpression (Figures 3A and 3B). Together with the finding
that AMPAR mEPSC frequency is significantly altered by miR-
137, we conclude that miR-137 specifically affects the number
of active synapses rather than changes spine morphology at
the CA3-CA1 synapse.
Next, we examined the mechanism through which miR-137
mediates synaptic depression. A plausible mechanism could
involve silencing of active synapses; i.e., synapses with
NMDARs but no functional AMPARs (Hanse et al., 2013). The
proportion of these silent synapses rapidly decreases during
the first 2 weeks of post-natal development in the hippocampus,
coinciding with the maturation process of the synapses (Liao
et al., 1999). We therefore measured the amount of surface
NMDAR subunit NR1 co-localizing with surface AMPAR subunit
GluA1 in hippocampal neurons infected at 8 DIV and immunola-
beled at 14 DIV. miR-137-overexpressing neurons exhibited a
significant increase in silent synapses, as fewer NR1 puncta
were co-localized with GluA1 puncta, while no significant
decrease in silent synapses in sponge-miR-137-infected neu-
rons was observed (Figures 3C and 3D).
To directly probe for a role of miR-137 in synapse silencing, we
measured the failure rate using a minimum stimulation protocol
(Isaac et al., 1995; Liao et al., 1995). Whole-cell patch-clamp re-
cordings were obtained from CA1 pyramidal neurons, clamped
Figure 1. GluA1 Is a Direct Target of
miR-137
(A) The binding site for the seed sequence for miR-
37 in the 30UTR of GluA1 is highly conserved
among human (hsa), rat (rno), and mouse (mmu)
sequences (shown in blue, from TargetScan
release 6.2).
(B) Overview of miR-137 target site within the rat
GluA1 30UTR. miR-137 seed sequence and the
nucleotide mutations inserted into the seed are
indicated in blue. The graph represents the relative
luciferase gene activity of a reporter vector
harboring either the WT GluA1 30UTR or mutated
GluA1 30UTR, when co-transfected with either
control or sponge-miR-137 (LNA-miRNA-NT or
LNA-miR-137, respectively). Luciferase activity
was normalized to Renilla luciferase activity. Error
bars represent the SEM for n = 8 independent
experiments; *p < 0.05, Student’s t test.
(C) Western blot shows GluA1 in cultured hippo-
campal neurons at 14 DIV, infected with lentivi-
ruses encoding either control (GFP alone),
sponge-miR-137, or miR-137 at 8 DIV; g-tubulin
was used as the loading control.
(D) Mean GluA1 protein levels in the different
conditions as indicated, normalized to g-tubulin
levels in the same sample, are shown (n = 6; *p <
0.05, one-way ANOVA).
(E) Mean GluA1 mRNA levels in the different con-
ditions as indicated are shown (n = 6; one-way
ANOVA).
(F) Representative confocal microscopy images
show sGluA1 expression, co-localizing with syn-
apsin-1, in cultured hippocampal neurons infected
with control (GFP alone), sponge-miR-137, or
miR-137 lentiviruses at 8 DIV and imaged at
14 DIV. Scale bars, 10 mm (top) and 2 mm (bottom).
See also Figure S1.
(G) Quantification shows the number of synaptic
sGluA1 puncta at synapses (n = 20–25 neurons
from three cultures/condition). Error bar repre-
sents SEM. *p < 0.05, **p < 0.01, one-way ANOVA.
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at their resting membrane potential (60 mV), and excitatory
synaptic transmission was elicited with a weak stimulus that pro-
duced failures in ±50% of the trials (Figure 3E). Fifty trials per
session were recorded at 60 and +40 mV for each cell, and
the failure rate at these two holding potentials was computed.
In non-infected 8-DIV CA1 neurons, the failure rate was larger
at 60 than at +40 mV (Figure 3F), indicating a substantial frac-
tion of the synapses are still silent at this stage of development
(Figure 3I). Neurons infected with the sponge-miR-137 showed
a similar failure rate measured at 60 mV compared with that
at +40 mV (Figure 3G), indicative of fewer silent synapses due
to a reduction in miR-137 levels (Figure 3I). Conversely, in CA1
hippocampal neurons overexpressing miR-137, we observed a
much higher rate of failures at 60 mV compared with that
at +40 mV (Figure 3H), indicative of a high fraction of silent syn-
apses in this condition. Together these data show that the
amount of silent synapses during development is significantly
altered upon miR-137 expression manipulation, and they sug-
gest that miR-137 acts as a synaptic break during development
by preventing the unsilencing of silent synapses.
miR-137 Is Required for mGluR-LTD Expression
Recent findings have shown that both LTP or LTD induction
rapidly alters the level of more than 50 different miRNAs in hip-
pocampal neurons (Park and Tang, 2009). Given our results
showing that miR-137 regulates AMPAR-mediated synaptic
strength, we hypothesized that miR-137 might also be required
for synaptic plasticity. We examined the role of miR-137 in
mGluR-LTD, a form of synaptic plasticity depending on local
protein translation at hippocampal neurons. We first examined
the temporal expression pattern of miR-137 after mGluR-LTD
induction. Using qPCR we found that LTD induced by the
mGluR group I agonist (S)-3,5-dihydroxyphenylglycine (DHPG)
rapidly increased mature miR-137 levels within 15 min after
DHPG application. Interestingly, the levels of miR-137 were
at baseline after 45 min (Figure 4A), suggesting a temporal
regulation. The finding that precursor (pre)-miR-137 levels are
concomitantly decreased 15 min after DHPG application (Fig-
ure 4B) suggested that this rapid regulation is possibly due
to an increased processing of pre-miR-137 into mature miR-
137 rather than enhanced miRNA transcription. Furthermore,
using specific mGluR1 or mGluR5 antagonists (LY367385 and
MPEP), we found that a DHPG-induced increase in mature
miR-137 levels was dependent on mGluR5, but not on mGluR1,
activation (Figure 4C).
Next, we examined whether mGluR5-induced miR-137 in-
crease is required for mGluR-LTD. We reasoned that acute
delivery of LNA-anti-miR-137 would only interfere with the
DHPG-induced miR-137 expression, without affecting basal
levels of miR-137. Indeed, introducing LNA-anti-miR-137 or con-
trol LNA-anti-miRNA-NT, into CA1 neurons of organotypic hip-
pocampal slices via whole-cell recording pipettes, did not affect
basal synaptic transmission when neurons were treated with the
respective LNA-anti-miRNAs for 60 min (Figure 4D). MGluR-LTD
can be induced chemically, using DHPG or by synaptic activa-
tion of mGluRs, using paired pulses of low-frequency (1 Hz) syn-
aptic stimulation (PP-LFS). Consistent with previous studies,
DHPG application (100 mM, 5 min) or PP-LFS caused an acute
depression in evoked EPSCs onto both neurons treated with
LNA-anti-miRNAs (Figures 4E and 4F). However, only a persis-
tent LTD was observed in LNA-anti-miRNA-NT-treated neurons,
but not in LNA-anti-miR-137 neurons (Figures 4E–4G).
Figure 2. Postsynaptic miR-137 Regulates
Synaptic Transmission
(A and B) (Top) Representative traces show
EPSCs recorded simultaneously from a pair of
uninfected neurons (control) and neurons infected
with indicated lentiviruses. EPSCs from both 60
and +40 mV holding potentials are shown. Scale
bars, 20 ms and 20 pA. (Bottom) Quantification
shows the EPSCs mediated by both AMPAR and
NMDAR for each experimental condition as indi-
cated. The EPSC amplitude was normalized to the
mean value of EPSCs from control neurons.
(A, sponge-miR-137, n = 14; B, miR-137, n = 12).
Data are shown as mean ± SEM. *p < 0.05, paired
Student’s t test.
(C) Paired-pulse ratio shows AMPAR-mediated
EPSCs at different time intervals for control,
sponge-miR-137-, and miR-137-expressing neu-
rons (n = 5 cells for all groups). Data are shown as
mean ± SEM.
(D) Representative traces show excitatory minia-
ture events recorded at 60 mV from unin-
fected neurons (control) and neurons expressing
sponge-miR-137 or miR-137. Scale bars, 250 ms
and 20 pA.
(E) Quantification shows mEPSC frequency and
amplitude for control, sponge-miR-137-, andmiR-
137-expressing neurons (n = 12 cells for all
groups). Data are shown as mean ± SEM. *p <
0.05, one-way ANOVA.
Cell Reports 11, 1876–1884, June 30, 2015 ª2015 The Authors 1879
Finally, miR-137 was selectively required for mGluR-LTD, as
no effect of manipulating miR-137 levels on NMDAR-induced
LTD was observed (Figure S2). Together these data show that
miR-137 is selectively required for mGluR5-mediated LTD.
DISCUSSION
miR-137 Regulates AMPAR Subunits and Synaptic
Transmission in Hippocampal Neurons
Small non-coding miRNAs recently have emerged as key regu-
lators of neuronal development and synaptic plasticity (Olde
Loohuis et al., 2012). In this study, we identified AMPAR subunit
GluA1 as a target of miR-137. By temporally and spatially
manipulating miR-137 levels at the hippocampal CA3-CA1
pathway, we demonstrate that postsynaptic miR-137 controls
maturation and plasticity of excitatory synaptic function by regu-
lating AMPAR expression. miR-137 repressed the incorporation
of AMPARs into the synaptic membrane, thereby preventing
synaptic maturation and plasticity. In particular, overexpressed
miR-137 in organotypic brain slices silenced active synapses,
likely by the removal of sGluA1. Conversely, decreased miR-
137 levels led to the accelerated maturation of excitatory
Figure 3. miR-137 Promotes Silencing of Active Synapses
(A) Representative confocal microscopy images show 21-DIV primary hippocampal neurons infected with control, sponge-miR-137, and miR-137 viruses at
8 DIV. Scale bars, 10 mm (top) and 1 mm (bottom).
(B) Quantification of spine density and size. Spine density is significantly increased in neurons expressing sponge-miR-137 compared to control neurons,
whereasmiR-137 overexpression shows no significant effect on spine density. miR-137manipulation does not show an effect on the percentage ofmature spines
or spine size (n = 35, control; n = 26, sponge-miR-137; and n = 24, miR-137). Bars represent mean ± SEM. *p < 0.05, one-way ANOVA.
(C) Representative confocal microscopy images show surface NR1 and sGluA1 expression in cultured hippocampal neurons infected with control (GFP alone),
sponge-miR-137, ormiR-137 lentivirus at 8 DIV and imaged at 14DIV.White arrows indicate GluA1/NR1 colocalization. Scale bars, 10 mm (top) and 2 mm (bottom).
(D) Quantification shows the number of NR1 puncta containing GluA1 (n = 11–14 neurons from three cultures/condition). Data are shown as mean ± SEM.
*p < 0.05, one-way ANOVA followed by post hoc Bonferroni correction for multiple testing.
(E) Representative traces were recorded from CA1 hippocampal neurons under minimal stimulation conditions at 60 and +40 mV holding potentials in control
neurons. Scale bars, 25 pA and 100 ms.
(F–H) Failure rates were obtained at 60 and +40 mV holding potentials in control (F), sponge-miR-137- (G), or miR-137-expressing neurons (H). Individual data
points (white squares) and average (gray square) are shown.
(I) Percentages show silent synapses in conditions as indicated. Data are shown as mean ± SEM (n = 10–11; *p < 0.05, **p < 0.01, one-way ANOVA).
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synapses, as they were prematurely converted from silent to
active synapses.
Our observations could have direct implications for how expe-
rience-driven activity drives early neuronal development, partic-
ularly in the context of neurodevelopmental disorders such as ID
and autism spectrum disorder (ASD) (Hanse et al., 2013).
Decreased levels of miR-137 during development may lead to
disturbed activity-dependent selection of AMPAR-silent synap-
ses by excessive and premature AMPAR unsilencing and subse-
quent synapse stabilization. Recently, in animal models of ASD,
such indiscriminative unsilencing of synapses has been shown
to lead to distorted neuronal network formation. For example,
haplo-insufficiency of Syngap1 in mice leads to premature matu-
ration of hippocampal and cortical synapses, resulting in a short-
ening of the critical period for plasticity (Clement et al., 2012,
2013).
The changes in synaptic AMPAR-mediated currents observed
in our study are likely a result of altered total GluA1 expression by
miR-137. However, we cannot exclude that molecular changes
induced by altering miR-137 also could impact directly AMPAR
trafficking or actin cytoskeleton dynamics. Of note, previous
gene ontology (GO) analysis of the transcriptome data (Collins
et al., 2014) suggests that the actin-remodeling pathway,
including the Rho GTPase pathway (Govek et al., 2005), is a
prominent signaling pathway that is targeted by miR-137. This
is of interest since neuronal plasticity requires both actin cyto-
skeleton remodeling and local protein translation in response
to extracellular signals (Zukin et al., 2009). Indeed, insertion
and removal of AMPARs in the context of LTP and LTD has
been shown to be dependent on actin polymerization (Bosch
and Hayashi, 2012; Cingolani and Goda, 2008). miR-137 may
thus trigger a selective removal of GluA1 from a subset of synap-
ses that subsequently become silent by targeting directly the
actin cytoskeleton pathway as well as impact directly the forma-
tion of dendritic spines. In this context, it is of note that the
density of dendritic spines also were increased in sponge-miR-
137-infected neurons. However, we did not observe any effects
on spine density upon miR-137 overexpression, which is in
accordance with a previous in vivo study in whichmiR-137 levels
were altered in hippocampal neurons (Smrt et al., 2010). Alterna-
tively, the effects on dendritic spines could be secondary to the
effects on GluA1 expression.
Figure 4. miR-137 Is Required for mGluR-
LTD Expression
(A) mGluR-LTD induced bymGluR group 1 agonist
DHPG (100 mM) enhances miR-137 levels after
15 min and miR-137 expression is decreased to
baseline levels after 45 min (n = 6 for control and
15 min; n = 3 for 45 min). Data are shown as
mean ± SEM. *p < 0.05, one-way ANOVA.
(B) mGluR-LTD induced by DHPG (100 mM) de-
creasesmiR-137 levels after 15min (n=3).Dataare
shown as mean ± SEM. *p < 0.05, unpaired t test.
(C) DHPG-induced increase in miR-137 levels is
blocked by mGluR5 antagonist MPEP (10 mM), but
not by themGluR1 antagonist LY-367385 (100 mM)
(n = 6 for control and DHPG; n = 3 for LY-367385
and MPEP). Data are shown as mean ± SEM. *p <
0.05, **p < 0.01, ***p < 0.001, one-way ANOVA.
(D) Average normalized EPSC amplitudes show
CA1 neurons from hippocampal slices infused
with LNA-miR-NT or with LNA-miR-137 (10 mM)
for 60 min (n = 4 pairs; paired t test).
(E and F) Normalized EPSC amplitudes plotted
against time from pairs of LNA-miRNA-NT and in-
fected LNA-miR-137-injected CA1 pyramidal neu-
rons during baseline (1) and after LTD induction (2)
withDHPG(E, 100mM,5min)orPP-LFSstimulation
(F, 1 Hz, 15 min, 50-ms interval). (Top) Represen-
tative traces showAMPAREPSCs before and after
LTD induction for control LNA-miRNA-NT (black)
and infused LNA-miR-137 (white) neurons. Scale
bars represent 25 ms and 30 pA. (Bottom) EPSC
amplitudes were normalized to the baseline of
control LNA-miRNA-NT and LNA-miR-137-filled
neurons (n = 8 pairs; data are shown as mean ±
SEM; *p < 0.05, measured between 50 and 55 min
after DHPG or PP-LFS treatment).
(G) AMPAR currents 50–55 min after DHPG or PP-
LFS application were normalized to baseline
AMPARcurrents for each indicatedcondition.Data
are shown as mean ± SEM. *p < 0.05, paired t test.
See also Figure S2.
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miR-137 and mGluR-LTD
In this paper, we provide evidence that miR-137 is necessary for
mGluR-LTD, a form of protein-synthesis-dependent synaptic
plasticity (Huber et al., 2000; Klann and Dever, 2004; Snyder
et al., 2001). Our experiments in organotypic hippocampal slices
revealed that miR-137 levels were upregulated 15 min following
LTD induction with DHPG, whereas pre-miR-137 expression
decreased within the same time span, suggesting possibly
increased miR-137 maturation upon DHPG-LTD. These data
are in line with a previous study in which more than 50 miRNAs
were found to be induced immediately after mGluR-LTD stimuli
in vitro (Park and Tang, 2009). This activity-dependent regulation
of miRNAs therefore suggests that they play a general role in
regulating protein synthesis during LTD expression. However,
to the best of our knowledge, only for miR-146a-5p and miR-
125a the requirement for mGluR-LTD has been demonstrated
directly (Chen and Shen, 2013; Muddashetty et al., 2011).
For miR-137, we addressed this question by using an
LNA-anti-miR-137 oligonucleotide that efficiently sequestered
endogenous miR-137. Using simultaneous recordings in orga-
notypic brain slices, we found that acute inhibition of miR-137
during LTD induction blocked LTD expression, suggesting that
this synaptically enriched miRNA indeed is necessary for
mGluR-LTD. Of interest is the time dependency of miR-137 up-
regulation. This has been observed for multiple miRNAs induced
after mGluR-LTD (Park and Tang, 2009), and it might represent a
general mechanism by which miRNAs may play a role in
restoring the repression state of mRNA translation after the tran-
sient activation (Ashraf and Kunes, 2006). Because mGluR-
induced miR-137 upregulation is transient, it may be required
for only a particular phase of LTD, for example, during the
consolidation phase. In line with this idea, we found that only
the later phase of LTD was affected and not the initial phase
when miR-137 function was blocked. Rapid upregulation of
miR-137 following LTD induction is thus possibly part of a pre-
cisely controlledmechanism tomaintain a defined pool of synap-
tic proteins involved in synaptic AMPAR expression.
In the present study, we found several lines of evidence for a
key role for miR-137 in controlling synaptic efficacy and plas-
ticity. Our study suggests that endogenous miR-137 functions
as a synaptic break during development and regulates excitatory
synaptic strength through direct modulation of GluA1 levels. In
conclusion, we link genetic deficits in MIR137 to glutamatergic
dysfunction, which may contribute to our understanding of the
pathogenesis of miR-137-linked cognitive impairments.
EXPERIMENTAL PROCEDURES
Virus production, luciferase assay, western blot, immunofluorescence, and
image analysis are described in the Supplemental Experimental Procedures.
miRNA Constructs
The sponge-miR-137 sequence was designed based on the rat miR-137-3p
sequence according to the original publication describing the application of
miRNA-sponge (Ebert et al., 2007; Kluiver et al., 2012). Briefly, the sponge-
miR-137-3p sequence contains four consecutive miR-137-3p binding sites,
each separated by four nucleotides. The miR-137 binding site contains bulged
sites that are non-complementary to the miR-137 positions 11–14, in order to
enhance sponge efficacy (Ebert et al., 2007; Gentner et al., 2009). Sponge-
miR-137 oligonucleotides contained recognition sequences for the restriction
enzymes BsrgI and EcoRI. Oligonucleotides (Sigma) were annealed in anneal-
ing buffer (containing 10 mM Tris [pH 7.5], 50 mM NaCl, and 1 mM EDTA)
through a 5-min incubation at 90C, followed by a slow cooldown to room tem-
perature. Annealed sponge-miR-137 oligonucleotides were ligated into the
FUGW vector (Plasmid 14883, Addgene) directly following the stop codon of
the eGFP cDNA. To create a lentiviral vector construct carrying the rat pre-
miR-137 cDNA, we PCR-amplified the precursor miR-137 containing flanking
70 nucleotides for both the 30 and 50 regions of the rat miR-137 from total rat
brain RNA, and we ligated the PCR product into the FUGW vector using the
BsrgI and EcoRI restriction sites.
Assessment of Sponge-miR-137 Function
The direct coupling of the concatemeric sponge-miR-137 sequence to the 30
site of the GFP cDNA allows efficient binding of miR-137 to the GFP-sponge-
miR-137-encoding transcript, ultimately resulting in an attenuation of GFP
translation. Reduced GFP fluorescent signal intensity therefore can be used
as a measure of sponge-miR-137 functional efficacy (Figure S1). For GFP
quantification, the sponge-miR-137-containing vector was transfected into
B35 rat neuroblastoma cells together with either a non-targeting (nt) mimic or
a mimic-miR-137 oligonucleotide using Lipofectamine 2000 (Life Technolo-
gies), according to the manufacturer’s instructions. Then, 48 hr post-transfec-
tion, cells were fixed in 4% paraformaldehyde (PFA)/sucrose in PBS and
visualized with a Leica DFC 420C fluorescence microscope using a 203
magnification. GFP quantification was performed using the ImageJ software.
We also detected significantly reduced endogenous miR-137 levels in
sponge-miR-137-infected neurons compared to GFP-infected neurons, as
measured by qPCR, suggesting that sponge-137 not only sequesters miR-
137 but also results in an enhanced turnover rate of this miRNA.
Electrophysiology
Whole-cell recordings in cultured slices were obtained with Multiclamp 700B
amplifiers (Axon Instruments). To study the effects of miR-137 on synaptic
transmission, cultured slices from P6–8 rats (Wistar, Harlan Laboratories)
were infected with control, sponge-miR-137, or miR-137 lentiviruses directly
upon plating. Then, 8 to 10 days later, whole-cell recordings were obtained
simultaneously from an infected and an adjacent uninfected neuron in the
CA1 region under visual guidance using epifluorescence and transmitted light
illumination. See the Supplemental Experimental Procedures for details.
Statistical Analysis
Statistical analyses were performed using Prism software (GraphPad). Statis-
tical tests were used with alpha level at 0.05. Two group comparisons were
evaluated using non-paired two-tailed t test. Three or more groups were eval-
uated using one-way ANOVA followed by post hoc Bonferroni correction for
multiple testing. Data are plotted as mean ± SEM. Quantification was per-
formed in a blinded fashion.
Animals
All experiments involving animals were evaluated and approved by the Com-
mittee for Animal Experiments of the Radboud University Nijmegen Medical
Centre, Nijmegen, the Netherlands.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and two figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2015.05.040.
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